← Back to Search

Electrolyte Solution

Lactated Ringer's Solution for Intestinal Diseases (LR Trial)

Phase 2
Waitlist Available
Led By Louis Beaumier, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

LR Trial Summary

The objective of this study is determining if enteral administration of Lactated Ringer's solution (LR) in preterm infants with feeding intolerance enables for faster advancement of milk feeding than fasting.

Eligible Conditions
  • Intestinal Diseases
  • Neonatal Feeding Disorder

LR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~variable
This trial's timeline: 3 weeks for screening, Varies for treatment, and variable for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average of the daily enteral caloric intake (in calories/kg/day) received over the 14 days after study entry
Secondary outcome measures
Electrolytes, bilirubin, serum urea nitrogen, creatinine and liver enzymes
Growth (weight, height, head circumference), increase % after 14 days and between study entry and discharge home
Infections
+4 more

LR Trial Design

2Treatment groups
Active Control
Group I: Lactated Ringer's SolutionActive Control1 Intervention
Group II: FastingActive Control1 Intervention

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
443 Previous Clinical Trials
159,438 Total Patients Enrolled
4 Trials studying Intestinal Diseases
3,410 Patients Enrolled for Intestinal Diseases
Louis Beaumier, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Gaelle Sadani, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025